| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 298.077 | 87 |
| GSM780708 | Untreated after 4 days (C2_1) | 407.875 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 364.888 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 308.907 | 88 |
| GSM780720 | Untreated after 4 days (C2_2) | 399.478 | 90 |
| GSM780721 | Untreated after 4 days (C3_2) | 326.536 | 88 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 397.608 | 90 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 365.915 | 89 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 344.09 | 89 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 369.81 | 89 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 388.459 | 90 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 357.427 | 89 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 315.354 | 88 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 338.685 | 88 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 321.688 | 88 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 319.984 | 88 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 335.606 | 88 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 346.915 | 89 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 506.932 | 92 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 387.291 | 90 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 385.58 | 90 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 494.362 | 91 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 440.73 | 91 |